September 2016

Optimizing Cord Blood and Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)

Condition:   Severe Aplastic Anemia
Interventions:   Drug: Antithymocyte Globulin;   Drug: Fludarabine;   Drug: Cyclophosphamide;   Radiation: Total Body Irradiation (TBI);   Procedure: UCB HSCT;   Procedure: Haplo HSCT;   Drug: Tacrolimus;   Drug: Mycophenolate mofetil (MMF);   Drug: G-CSF
Sponsors:   Medical College of Wisconsin;   National Heart, Lung, and Blood Institute (NHLBI);   National Cancer Institute (NCI);   Blood and Marrow Transplant Clinical Trials Network;   National Marrow Donor Program
Not yet recruiting - verified November 2016

Population-Based Ohio ALS Repository and ALS Risk Factors

Condition:   Amyotrophic Lateral Sclerosis
Intervention:   Other: Patient Registry
Sponsors:   Dartmouth-Hitchcock Medical Center;   The Cleveland Clinic
Not yet recruiting - verified September 2016

Smoking May Cut Life Expectancy in ALS

Dr Chiò serves on the editorial advisory board of Amyotrophic Lateral Sclerosis and has received research support from the Italian Ministry of Health, Regione Piemonte, University of Turin, Fondazione Vialli e Mauro onlus, and the European Commission.

Synthetic Oil Delayed ALS Symptoms In Mice: Study

A potential treatment may help delay motor neuron loss in amyotrophic lateral sclerosis, a disease brought into the spotlight by the ice bucket challenge. AsianScientist (Sep. 26, 2016) - New research in mice brings hope that triheptanoin, a synthetic ...

Pages